Efficacy and Safety of Combination Eribulin + Pembrolizumab

Efficacy and Safety of Combination Eribulin + Pembrolizumab

obr

2 months
374 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Womens Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School elaborates on the efficacy and safety of combination eribulin and pembrolizumab in metastatic breast cancer.
Up Next Autoplay